ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Insulin Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-21V7274
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Human Insulin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Human Insulin Market Research Report 2025

Code: QYRE-Auto-21V7274
Report
August 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
B. Braun
Becton Dickinson
Biocon Ltd.
Biodel
Eli Lilly
Julphar
Novo Nordisk
Sanofi
WOCKHARDT
Ypsomed

Human Insulin Market Size

The global market for Human Insulin was valued at US$ 66950 million in the year 2024 and is projected to reach a revised size of US$ 124170 million by 2031, growing at a CAGR of 9.4% during the forecast period.

Human Insulin Market

Human Insulin Market

Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans.
In 2018, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulatory framework for marketing approvals & medical reimbursements, continued expansion of advanced medical facilities in emerging countries (such as China & India), and rising public awareness related to benefits offered by human insulin in diabetes treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Insulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Insulin.
The Human Insulin market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Insulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Insulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Insulin Market Report

Report Metric Details
Report Name Human Insulin Market
Accounted market size in year US$ 66950 million
Forecasted market size in 2031 US$ 124170 million
CAGR 9.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Insulin Analogs and Biosimilars
  • Human Insulin Biologics
Segment by Application
  • Short Acting
  • Intermediate Acting
  • Long Acting
  • Pre-Mix Insulin
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company B. Braun, Becton, Dickinson, Biocon, Biodel, ELI Lilly, Julphar, NOVO Nordisk, Sanofi, Wockhardt, Ypsomed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Insulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Insulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Human Insulin Market growing?

Ans: The Human Insulin Market witnessing a CAGR of 9.4% during the forecast period 2025-2031.

What is the Human Insulin Market size in 2031?

Ans: The Human Insulin Market size in 2031 will be US$ 124170 million.

Who are the main players in the Human Insulin Market report?

Ans: The main players in the Human Insulin Market are B. Braun, Becton, Dickinson, Biocon, Biodel, ELI Lilly, Julphar, NOVO Nordisk, Sanofi, Wockhardt, Ypsomed

What are the Application segmentation covered in the Human Insulin Market report?

Ans: The Applications covered in the Human Insulin Market report are Short Acting, Intermediate Acting, Long Acting, Pre-Mix Insulin

What are the Type segmentation covered in the Human Insulin Market report?

Ans: The Types covered in the Human Insulin Market report are Insulin Analogs and Biosimilars, Human Insulin Biologics

1 Human Insulin Market Overview
1.1 Product Definition
1.2 Human Insulin by Type
1.2.1 Global Human Insulin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Insulin Analogs and Biosimilars
1.2.3 Human Insulin Biologics
1.3 Human Insulin by Application
1.3.1 Global Human Insulin Market Value by Application (2024 VS 2031)
1.3.2 Short Acting
1.3.3 Intermediate Acting
1.3.4 Long Acting
1.3.5 Pre-Mix Insulin
1.4 Global Human Insulin Market Size Estimates and Forecasts
1.4.1 Global Human Insulin Revenue 2020-2031
1.4.2 Global Human Insulin Sales 2020-2031
1.4.3 Global Human Insulin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Insulin Market Competition by Manufacturers
2.1 Global Human Insulin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Insulin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Insulin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Insulin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Insulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Insulin, Product Type & Application
2.7 Global Key Manufacturers of Human Insulin, Date of Enter into This Industry
2.8 Global Human Insulin Market Competitive Situation and Trends
2.8.1 Global Human Insulin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Insulin Players Market Share by Revenue
2.8.3 Global Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Insulin Market Scenario by Region
3.1 Global Human Insulin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Insulin Sales by Region: 2020-2031
3.2.1 Global Human Insulin Sales by Region: 2020-2025
3.2.2 Global Human Insulin Sales by Region: 2026-2031
3.3 Global Human Insulin Revenue by Region: 2020-2031
3.3.1 Global Human Insulin Revenue by Region: 2020-2025
3.3.2 Global Human Insulin Revenue by Region: 2026-2031
3.4 North America Human Insulin Market Facts & Figures by Country
3.4.1 North America Human Insulin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Insulin Sales by Country (2020-2031)
3.4.3 North America Human Insulin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Insulin Market Facts & Figures by Country
3.5.1 Europe Human Insulin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Insulin Sales by Country (2020-2031)
3.5.3 Europe Human Insulin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Insulin Market Facts & Figures by Region
3.6.1 Asia Pacific Human Insulin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Insulin Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Insulin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Insulin Market Facts & Figures by Country
3.7.1 Latin America Human Insulin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Insulin Sales by Country (2020-2031)
3.7.3 Latin America Human Insulin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Insulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Insulin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Insulin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Insulin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Insulin Sales by Type (2020-2031)
4.1.1 Global Human Insulin Sales by Type (2020-2025)
4.1.2 Global Human Insulin Sales by Type (2026-2031)
4.1.3 Global Human Insulin Sales Market Share by Type (2020-2031)
4.2 Global Human Insulin Revenue by Type (2020-2031)
4.2.1 Global Human Insulin Revenue by Type (2020-2025)
4.2.2 Global Human Insulin Revenue by Type (2026-2031)
4.2.3 Global Human Insulin Revenue Market Share by Type (2020-2031)
4.3 Global Human Insulin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Insulin Sales by Application (2020-2031)
5.1.1 Global Human Insulin Sales by Application (2020-2025)
5.1.2 Global Human Insulin Sales by Application (2026-2031)
5.1.3 Global Human Insulin Sales Market Share by Application (2020-2031)
5.2 Global Human Insulin Revenue by Application (2020-2031)
5.2.1 Global Human Insulin Revenue by Application (2020-2025)
5.2.2 Global Human Insulin Revenue by Application (2026-2031)
5.2.3 Global Human Insulin Revenue Market Share by Application (2020-2031)
5.3 Global Human Insulin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 B. Braun
6.1.1 B. Braun Company Information
6.1.2 B. Braun Description and Business Overview
6.1.3 B. Braun Human Insulin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 B. Braun Human Insulin Product Portfolio
6.1.5 B. Braun Recent Developments/Updates
6.2 Becton, Dickinson
6.2.1 Becton, Dickinson Company Information
6.2.2 Becton, Dickinson Description and Business Overview
6.2.3 Becton, Dickinson Human Insulin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Becton, Dickinson Human Insulin Product Portfolio
6.2.5 Becton, Dickinson Recent Developments/Updates
6.3 Biocon
6.3.1 Biocon Company Information
6.3.2 Biocon Description and Business Overview
6.3.3 Biocon Human Insulin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Biocon Human Insulin Product Portfolio
6.3.5 Biocon Recent Developments/Updates
6.4 Biodel
6.4.1 Biodel Company Information
6.4.2 Biodel Description and Business Overview
6.4.3 Biodel Human Insulin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biodel Human Insulin Product Portfolio
6.4.5 Biodel Recent Developments/Updates
6.5 ELI Lilly
6.5.1 ELI Lilly Company Information
6.5.2 ELI Lilly Description and Business Overview
6.5.3 ELI Lilly Human Insulin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 ELI Lilly Human Insulin Product Portfolio
6.5.5 ELI Lilly Recent Developments/Updates
6.6 Julphar
6.6.1 Julphar Company Information
6.6.2 Julphar Description and Business Overview
6.6.3 Julphar Human Insulin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Julphar Human Insulin Product Portfolio
6.6.5 Julphar Recent Developments/Updates
6.7 NOVO Nordisk
6.7.1 NOVO Nordisk Company Information
6.7.2 NOVO Nordisk Description and Business Overview
6.7.3 NOVO Nordisk Human Insulin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NOVO Nordisk Human Insulin Product Portfolio
6.7.5 NOVO Nordisk Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Company Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Human Insulin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanofi Human Insulin Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Wockhardt
6.9.1 Wockhardt Company Information
6.9.2 Wockhardt Description and Business Overview
6.9.3 Wockhardt Human Insulin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Wockhardt Human Insulin Product Portfolio
6.9.5 Wockhardt Recent Developments/Updates
6.10 Ypsomed
6.10.1 Ypsomed Company Information
6.10.2 Ypsomed Description and Business Overview
6.10.3 Ypsomed Human Insulin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ypsomed Human Insulin Product Portfolio
6.10.5 Ypsomed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Insulin Industry Chain Analysis
7.2 Human Insulin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Insulin Production Mode & Process Analysis
7.4 Human Insulin Sales and Marketing
7.4.1 Human Insulin Sales Channels
7.4.2 Human Insulin Distributors
7.5 Human Insulin Customer Analysis
8 Human Insulin Market Dynamics
8.1 Human Insulin Industry Trends
8.2 Human Insulin Market Drivers
8.3 Human Insulin Market Challenges
8.4 Human Insulin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
B. Braun
Becton Dickinson
Biocon Ltd.
Biodel
Eli Lilly
Julphar
Novo Nordisk
Sanofi
WOCKHARDT
Ypsomed
List of Tables
 Table 1. Global Human Insulin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Insulin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Insulin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Insulin Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Human Insulin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Insulin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Insulin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Insulin Average Price (USD/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Insulin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Insulin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Insulin, Product Type & Application
 Table 12. Global Key Manufacturers of Human Insulin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Insulin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Insulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Insulin Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Human Insulin Sales Market Share by Region (2020-2025)
 Table 19. Global Human Insulin Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Human Insulin Sales Market Share by Region (2026-2031)
 Table 21. Global Human Insulin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Insulin Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Insulin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Insulin Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Insulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Insulin Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Human Insulin Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Human Insulin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Insulin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Insulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Insulin Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Human Insulin Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Human Insulin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Insulin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Insulin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Insulin Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Human Insulin Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Human Insulin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Insulin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Insulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Insulin Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Human Insulin Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Human Insulin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Insulin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Insulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Insulin Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Human Insulin Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Human Insulin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Insulin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Insulin Sales (K Doses) by Type (2020-2025)
 Table 51. Global Human Insulin Sales (K Doses) by Type (2026-2031)
 Table 52. Global Human Insulin Sales Market Share by Type (2020-2025)
 Table 53. Global Human Insulin Sales Market Share by Type (2026-2031)
 Table 54. Global Human Insulin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Insulin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Insulin Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Insulin Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Insulin Price (USD/Dose) by Type (2020-2025)
 Table 59. Global Human Insulin Price (USD/Dose) by Type (2026-2031)
 Table 60. Global Human Insulin Sales (K Doses) by Application (2020-2025)
 Table 61. Global Human Insulin Sales (K Doses) by Application (2026-2031)
 Table 62. Global Human Insulin Sales Market Share by Application (2020-2025)
 Table 63. Global Human Insulin Sales Market Share by Application (2026-2031)
 Table 64. Global Human Insulin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Insulin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Insulin Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Insulin Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Insulin Price (USD/Dose) by Application (2020-2025)
 Table 69. Global Human Insulin Price (USD/Dose) by Application (2026-2031)
 Table 70. B. Braun Company Information
 Table 71. B. Braun Description and Business Overview
 Table 72. B. Braun Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 73. B. Braun Human Insulin Product
 Table 74. B. Braun Recent Developments/Updates
 Table 75. Becton, Dickinson Company Information
 Table 76. Becton, Dickinson Description and Business Overview
 Table 77. Becton, Dickinson Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 78. Becton, Dickinson Human Insulin Product
 Table 79. Becton, Dickinson Recent Developments/Updates
 Table 80. Biocon Company Information
 Table 81. Biocon Description and Business Overview
 Table 82. Biocon Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 83. Biocon Human Insulin Product
 Table 84. Biocon Recent Developments/Updates
 Table 85. Biodel Company Information
 Table 86. Biodel Description and Business Overview
 Table 87. Biodel Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 88. Biodel Human Insulin Product
 Table 89. Biodel Recent Developments/Updates
 Table 90. ELI Lilly Company Information
 Table 91. ELI Lilly Description and Business Overview
 Table 92. ELI Lilly Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 93. ELI Lilly Human Insulin Product
 Table 94. ELI Lilly Recent Developments/Updates
 Table 95. Julphar Company Information
 Table 96. Julphar Description and Business Overview
 Table 97. Julphar Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 98. Julphar Human Insulin Product
 Table 99. Julphar Recent Developments/Updates
 Table 100. NOVO Nordisk Company Information
 Table 101. NOVO Nordisk Description and Business Overview
 Table 102. NOVO Nordisk Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 103. NOVO Nordisk Human Insulin Product
 Table 104. NOVO Nordisk Recent Developments/Updates
 Table 105. Sanofi Company Information
 Table 106. Sanofi Description and Business Overview
 Table 107. Sanofi Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 108. Sanofi Human Insulin Product
 Table 109. Sanofi Recent Developments/Updates
 Table 110. Wockhardt Company Information
 Table 111. Wockhardt Description and Business Overview
 Table 112. Wockhardt Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 113. Wockhardt Human Insulin Product
 Table 114. Wockhardt Recent Developments/Updates
 Table 115. Ypsomed Company Information
 Table 116. Ypsomed Description and Business Overview
 Table 117. Ypsomed Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 118. Ypsomed Human Insulin Product
 Table 119. Ypsomed Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Human Insulin Distributors List
 Table 123. Human Insulin Customers List
 Table 124. Human Insulin Market Trends
 Table 125. Human Insulin Market Drivers
 Table 126. Human Insulin Market Challenges
 Table 127. Human Insulin Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Insulin
 Figure 2. Global Human Insulin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Insulin Market Share by Type: 2024 & 2031
 Figure 4. Insulin Analogs and Biosimilars Product Picture
 Figure 5. Human Insulin Biologics Product Picture
 Figure 6. Global Human Insulin Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Human Insulin Market Share by Application: 2024 & 2031
 Figure 8. Short Acting
 Figure 9. Intermediate Acting
 Figure 10. Long Acting
 Figure 11. Pre-Mix Insulin
 Figure 12. Global Human Insulin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Human Insulin Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Human Insulin Sales (2020-2031) & (K Doses)
 Figure 15. Global Human Insulin Average Price (USD/Dose) & (2020-2031)
 Figure 16. Human Insulin Report Years Considered
 Figure 17. Human Insulin Sales Share by Manufacturers in 2024
 Figure 18. Global Human Insulin Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Human Insulin Players: Market Share by Revenue in Human Insulin in 2024
 Figure 20. Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Human Insulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Human Insulin Sales Market Share by Country (2020-2031)
 Figure 23. North America Human Insulin Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Human Insulin Sales Market Share by Country (2020-2031)
 Figure 27. Europe Human Insulin Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Human Insulin Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Human Insulin Revenue Market Share by Region (2020-2031)
 Figure 35. China Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Human Insulin Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Human Insulin Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Human Insulin Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Human Insulin Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Human Insulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Human Insulin by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Human Insulin by Type (2020-2031)
 Figure 57. Global Human Insulin Price (USD/Dose) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Human Insulin by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Human Insulin by Application (2020-2031)
 Figure 60. Global Human Insulin Price (USD/Dose) by Application (2020-2031)
 Figure 61. Human Insulin Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Recombinant Human Insulin Market Insights Forecast to 2030
Global Human Insulin Regular Market Research Report 2025
Global Human Insulin Injections Market Research Report 2024
Global Human Insulin Drugs Market Research Report 2025
Global Fast acting Human Insulin Market Research Report 2024
Global Human Recombinant Insulin Market Research Report 2024
Global Premixed Human Insulin Market Research Report 2024
Global Human Insulin Delivery System Market Insights Forecast to 2030
Global Insulin API Market Insights Forecast to 2030
Global Human Insulin Drugs And Delivery Devices Market Insights Forecast to 2030
Global Mixed Recombinant Human Insulin Injection Market Research Report 2024
Global Insulin Raw Material Market Research Report 2025
Global Insulin Drugs for Diabetes Market Research Report 2024
Global Recombinant Insulin Analogue Market Research Report 2024
Global Insulin Analog Market Research Report 2025
Global Insulin Storage Devices Market Research Report 2024
Biosimilar Insulin Market
Global Animal Insulin Market Insights Forecast to 2030
Global Insulin Preparation Market Research Report 2025
Global Synthetic Human Growth Hormone Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions